Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: Nine novel mutations including T312S, a common allele that confers a mild phenotype

Naoto Yamada, Seiji Fukuda, Shunji Tomatsu, Vivienne Muller, John J. Hopwood, John Nelson, Zenichiro Kato, Atushi Yamagishi, Kazuko Sukegawa, Naomi Kondo, Tadao Orii

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive lysosomal storage disorder caused by a genetic defect in N-acetylgalactosamine-6- sulfate sulfatase (GALNS). Previous studies of patients from a British-Irish population showed that the I113F mutation is the most common single mutation among MPS IVA patients and produces a severe clinical phenotype. We studied mutations in the GALNS gene from 23 additional MPS IVA patients (15 from Australia, 8 from Northern Ireland), with various clinical phenotypes (severe, 16 cases; intermediate, 4 cases; mild, 3 cases). We found two common mutations that together accounted for 32% of the 44 unrelated alleles in these patients. One is the T312S mutation, a novel mutation found exclusively in milder patients. The other is the previously described I113F that produces a severe phenotype. The I113F and T312S mutations accounted for 8 (18%) and 6 (14%) of 44 unrelated alleles, respectively. The relatively high residual GALNS activity seen when the T312S mutant cDNA is overexpressed in mutant cells provides an explanation for the mild phenotype in patients with this mutation. The distribution and relative frequencies of the I113F and T312S mutations in Australia corresponded to those observed in Northern Ireland and are unique to these two populations, suggesting that both mutations were probably introduced to Australia by Irish migrants during the 19th century. Haplotype analysis using 6 RFLPs provides additional data that the I113F mutation originated from a common ancestor. The other 9 novel mutations identified in these 23 patients were each limited to a single family. These data provide further evidence for extensive allelic heterogeneity in MPS IVA in British-Irish patients and provide evidence for their transmission to Australia by British-Irish migrants.

LanguageEnglish
Pages202-208
Number of pages7
JournalHuman Mutation
Volume11
Issue number3
DOIs
Publication statusPublished - 4 Apr 1998

Keywords

  • Allelic heterogeneity
  • Common mutations
  • Mucopolysaccharidosis IVA
  • N-acetylgalactosamine-6-sulfate sulfatase

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Yamada, Naoto ; Fukuda, Seiji ; Tomatsu, Shunji ; Muller, Vivienne ; Hopwood, John J. ; Nelson, John ; Kato, Zenichiro ; Yamagishi, Atushi ; Sukegawa, Kazuko ; Kondo, Naomi ; Orii, Tadao. / Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland : Nine novel mutations including T312S, a common allele that confers a mild phenotype. In: Human Mutation. 1998 ; Vol. 11, No. 3. pp. 202-208.
@article{943711cbfd52453db4bab8597a8b85bf,
title = "Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: Nine novel mutations including T312S, a common allele that confers a mild phenotype",
abstract = "Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive lysosomal storage disorder caused by a genetic defect in N-acetylgalactosamine-6- sulfate sulfatase (GALNS). Previous studies of patients from a British-Irish population showed that the I113F mutation is the most common single mutation among MPS IVA patients and produces a severe clinical phenotype. We studied mutations in the GALNS gene from 23 additional MPS IVA patients (15 from Australia, 8 from Northern Ireland), with various clinical phenotypes (severe, 16 cases; intermediate, 4 cases; mild, 3 cases). We found two common mutations that together accounted for 32{\%} of the 44 unrelated alleles in these patients. One is the T312S mutation, a novel mutation found exclusively in milder patients. The other is the previously described I113F that produces a severe phenotype. The I113F and T312S mutations accounted for 8 (18{\%}) and 6 (14{\%}) of 44 unrelated alleles, respectively. The relatively high residual GALNS activity seen when the T312S mutant cDNA is overexpressed in mutant cells provides an explanation for the mild phenotype in patients with this mutation. The distribution and relative frequencies of the I113F and T312S mutations in Australia corresponded to those observed in Northern Ireland and are unique to these two populations, suggesting that both mutations were probably introduced to Australia by Irish migrants during the 19th century. Haplotype analysis using 6 RFLPs provides additional data that the I113F mutation originated from a common ancestor. The other 9 novel mutations identified in these 23 patients were each limited to a single family. These data provide further evidence for extensive allelic heterogeneity in MPS IVA in British-Irish patients and provide evidence for their transmission to Australia by British-Irish migrants.",
keywords = "Allelic heterogeneity, Common mutations, Mucopolysaccharidosis IVA, N-acetylgalactosamine-6-sulfate sulfatase",
author = "Naoto Yamada and Seiji Fukuda and Shunji Tomatsu and Vivienne Muller and Hopwood, {John J.} and John Nelson and Zenichiro Kato and Atushi Yamagishi and Kazuko Sukegawa and Naomi Kondo and Tadao Orii",
year = "1998",
month = "4",
day = "4",
doi = "10.1002/(SICI)1098-1004(1998)11:3<202::AID-HUMU4>3.0.CO;2-J",
language = "English",
volume = "11",
pages = "202--208",
journal = "Human mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "3",

}

Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland : Nine novel mutations including T312S, a common allele that confers a mild phenotype. / Yamada, Naoto; Fukuda, Seiji; Tomatsu, Shunji; Muller, Vivienne; Hopwood, John J.; Nelson, John; Kato, Zenichiro; Yamagishi, Atushi; Sukegawa, Kazuko; Kondo, Naomi; Orii, Tadao.

In: Human Mutation, Vol. 11, No. 3, 04.04.1998, p. 202-208.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland

T2 - Human mutation

AU - Yamada, Naoto

AU - Fukuda, Seiji

AU - Tomatsu, Shunji

AU - Muller, Vivienne

AU - Hopwood, John J.

AU - Nelson, John

AU - Kato, Zenichiro

AU - Yamagishi, Atushi

AU - Sukegawa, Kazuko

AU - Kondo, Naomi

AU - Orii, Tadao

PY - 1998/4/4

Y1 - 1998/4/4

N2 - Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive lysosomal storage disorder caused by a genetic defect in N-acetylgalactosamine-6- sulfate sulfatase (GALNS). Previous studies of patients from a British-Irish population showed that the I113F mutation is the most common single mutation among MPS IVA patients and produces a severe clinical phenotype. We studied mutations in the GALNS gene from 23 additional MPS IVA patients (15 from Australia, 8 from Northern Ireland), with various clinical phenotypes (severe, 16 cases; intermediate, 4 cases; mild, 3 cases). We found two common mutations that together accounted for 32% of the 44 unrelated alleles in these patients. One is the T312S mutation, a novel mutation found exclusively in milder patients. The other is the previously described I113F that produces a severe phenotype. The I113F and T312S mutations accounted for 8 (18%) and 6 (14%) of 44 unrelated alleles, respectively. The relatively high residual GALNS activity seen when the T312S mutant cDNA is overexpressed in mutant cells provides an explanation for the mild phenotype in patients with this mutation. The distribution and relative frequencies of the I113F and T312S mutations in Australia corresponded to those observed in Northern Ireland and are unique to these two populations, suggesting that both mutations were probably introduced to Australia by Irish migrants during the 19th century. Haplotype analysis using 6 RFLPs provides additional data that the I113F mutation originated from a common ancestor. The other 9 novel mutations identified in these 23 patients were each limited to a single family. These data provide further evidence for extensive allelic heterogeneity in MPS IVA in British-Irish patients and provide evidence for their transmission to Australia by British-Irish migrants.

AB - Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive lysosomal storage disorder caused by a genetic defect in N-acetylgalactosamine-6- sulfate sulfatase (GALNS). Previous studies of patients from a British-Irish population showed that the I113F mutation is the most common single mutation among MPS IVA patients and produces a severe clinical phenotype. We studied mutations in the GALNS gene from 23 additional MPS IVA patients (15 from Australia, 8 from Northern Ireland), with various clinical phenotypes (severe, 16 cases; intermediate, 4 cases; mild, 3 cases). We found two common mutations that together accounted for 32% of the 44 unrelated alleles in these patients. One is the T312S mutation, a novel mutation found exclusively in milder patients. The other is the previously described I113F that produces a severe phenotype. The I113F and T312S mutations accounted for 8 (18%) and 6 (14%) of 44 unrelated alleles, respectively. The relatively high residual GALNS activity seen when the T312S mutant cDNA is overexpressed in mutant cells provides an explanation for the mild phenotype in patients with this mutation. The distribution and relative frequencies of the I113F and T312S mutations in Australia corresponded to those observed in Northern Ireland and are unique to these two populations, suggesting that both mutations were probably introduced to Australia by Irish migrants during the 19th century. Haplotype analysis using 6 RFLPs provides additional data that the I113F mutation originated from a common ancestor. The other 9 novel mutations identified in these 23 patients were each limited to a single family. These data provide further evidence for extensive allelic heterogeneity in MPS IVA in British-Irish patients and provide evidence for their transmission to Australia by British-Irish migrants.

KW - Allelic heterogeneity

KW - Common mutations

KW - Mucopolysaccharidosis IVA

KW - N-acetylgalactosamine-6-sulfate sulfatase

UR - http://www.scopus.com/inward/record.url?scp=6844251004&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-1004(1998)11:3<202::AID-HUMU4>3.0.CO;2-J

DO - 10.1002/(SICI)1098-1004(1998)11:3<202::AID-HUMU4>3.0.CO;2-J

M3 - Article

VL - 11

SP - 202

EP - 208

JO - Human mutation

JF - Human mutation

SN - 1059-7794

IS - 3

ER -